These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16708649)

  • 1. [Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2006 Feb; 20(116):236-41. PubMed ID: 16708649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Riepe FG; Sippell WG
    Rev Endocr Metab Disord; 2007 Dec; 8(4):349-63. PubMed ID: 17885806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.
    Parsa AA; New MI
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):2-11. PubMed ID: 27380651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal diagnosis and treatment of congenital adrenal hyperplasia.
    Nimkarn S; New MI
    Horm Res; 2007; 67(2):53-60. PubMed ID: 17047340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Congenital adrenal hyperplasia due to 21 hydroxylase deficiency--case report].
    Vlaski J; Katanić D; Kavecan I; Dautović S; Vorgucin I
    Med Pregl; 2008; 61(3-4):183-6. PubMed ID: 18773697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Nimkarn S; New MI
    Mol Cell Endocrinol; 2009 Mar; 300(1-2):192-6. PubMed ID: 19101608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraadrenal steroid 21-hydroxylase activity in a woman with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency.
    Winkel CA; Casey ML; Worley RJ; Madden JD; MacDonald PC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):104-7. PubMed ID: 6600168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital adrenal hyperplasia: focus on the molecular basis of 21-hydroxylase deficiency.
    Gonçalves J; Friães A; Moura L
    Expert Rev Mol Med; 2007 Apr; 9(11):1-23. PubMed ID: 17466088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia.
    Nimkarn S; Lin-Su K; New MI
    Endocrinol Metab Clin North Am; 2009 Dec; 38(4):699-718. PubMed ID: 19944288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    White PC; Speiser PW
    Endocr Rev; 2000 Jun; 21(3):245-91. PubMed ID: 10857554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Forest MG
    Hum Reprod Update; 2004; 10(6):469-85. PubMed ID: 15514016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rare congenital defects of adrenal steroidogenesis].
    Krysiak R; Marek B; Okopień B
    Endokrynol Pol; 2008; 59(4):354-65. PubMed ID: 18777507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Merke DP; Bornstein SR; Avila NA; Chrousos GP
    Ann Intern Med; 2002 Feb; 136(4):320-34. PubMed ID: 11848730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update of congenital adrenal hyperplasia.
    New MI
    Ann N Y Acad Sci; 2004 Dec; 1038():14-43. PubMed ID: 15838095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible cardiomyopathy caused by an uncommon form of congenital adrenal hyperplasia.
    Al Jarallah AS
    Pediatr Cardiol; 2004; 25(6):675-6. PubMed ID: 15136908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Steroid 21-hydroxylase deficiency, the most frequent cause of congenital adrenal hyperplasia].
    Doleschall M; Török D; Mészáros K; Luczay A; Halász Z; Németh K; Szücs N; Kiss R; Tőke J; Sólyom J; Fekete G; Patócs A; Igaz P; Tóth M
    Orv Hetil; 2018 Feb; 159(7):269-277. PubMed ID: 29429350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of congenital adrenal hyperplasia.
    New MI
    Annu Rev Med; 1998; 49():311-28. PubMed ID: 9509266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
    Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the best approach to the teenage patient presenting with nonclassical congenital adrenal hyperplasia: should we always treat with glucocorticoids?
    Matthews D; Cheetham T
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):338-41. PubMed ID: 23039910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.
    Kawashima Y; Usui T; Fujimoto M; Miyahara N; Nishimura R; Hanaki K; Kanzaki S
    Endocr J; 2015; 62(1):101-6. PubMed ID: 25319875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.